Michael Sullivan, Ikhwan Lee, Jinsuk Chung et al. · 2013
are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. Government. 1Abstract Future large-scale computer systems will require a comprehensive and flexible resilience solution to maintain correctness while satisfying strict energy constraints. Toward this end, this document presents the definition of the semantics of scalable and efficient containment domains (CDs) resilience framework. Containment domains are a programming construct that enables applications to express, tune, and specialize error detection, state preservation and restoration, and recovery to satisfy application-specific resilience needs. Containment domains have weak transactional semantics and are nested to take advantage of deep machine and application hierarchies. The flexibility and hierarchy of containment domains enables the programmer and software system to match state preservation, error detection, and recovery costs with the rate and severity of errors. Containment domains also empower the programmer to reason about resiliency and to utilize domain knowledge to improve efficiency beyond what compiler analysis can achieve without such information. This report describes CD semantics and identifies the system features and mechanisms required for an efficient containment domains implementation. Revision History Version 0.1 October 2013 • Initial draft for public comments
Cited by 0
Gritzmann, P., Klee, V., Trier Univ. (Germany). Fachbereich 4 - Wirtschafts- und Sozialwissenschaften/Mathematik · OpenGrey (Institut de l'Information Scientifique et Technique) · 1993
The present paper is the first part of a survey of computational convexity, a new area of applied mathematics which has crystallized aroud a variety of results, problems and applications that involve interactions among convex geometry, mathematical programming and computer science. This first part will begin with some general remarks on computational convexity and will then summarize three paradigmatic areas of the subject. However, its main focus is on recent results that are related to the basic problems of computing, approximating, or measuring the convex sets which, among those in a given class C, are the smallest that contain a given convex body K or are the largest contained in K
Cited by 0
Faiz Ul Muram, Huy Tran, Uwe Zdun · Science of Computer Programming · 2019
Cited by 8
Samson O. Ojoawo, Jamiu A. Dauda, Olatunde Afeez Salami · Journal of Civil Engineering and Architecture · 2012
The effectiveness of geonet, geotextile and their composite as containment materials of landfill leachate has been examined in this paper through the use of system dynamics modeling method. The study area is Oriire Local Government Area of Oyo State, Nigeria. Three materials were studied, which include: GN (geonet), GT (geotextile) and GC (geocomposite). The water absorption, hydraulic conductivity, porosity and thickness were the major properties studied in these liners. Governing equations coded in Visual Basic Computer Programming Language was employed in developing a model. Validation of the model was done with data on the study area. The interrelationship of the properties and the breakthrough times for each material was found through the STELLA 9.1.4 software application. This research showed that the effectiveness of the studied of the order GC < GN < GT. GT is, therefore, recommended for use as landfill liners in the study area.
Cited by 1Open access
Mark K. Joseph, A. Avižienis · 2003
Extensions of program flow monitors and n-version programming can be combined to provide a solution to the detection and containment of computer viruses. The consequence is that a computer can tolerate both deliberate faults and random physical faults by one common mechanism. Specifically, the technique detects control flow errors due to physical faults as well as the presence of viruses.< <ETX xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">></ETX>
Cited by 71
Gritzmann, P., Klee, V., Trier Univ. (Germany). Fachbereich IV - Wirtschafts- und Sozialwissenschaften/Mathematik/Informatik · OpenGrey (Institut de l'Information Scientifique et Technique) · 1993
This paper is the second part of a broader survey of computational convexity, an area of mathematics that has crystallized around a variety of results, problems and applications involving interactions among convex geometry, mathematical programming and computer science. The first part (GrK94a) discussed containment problems. This second part is concerned with computing volumes and mixed volumes of convex polytopes and more general convex bodies. In order to keep the paper self-contained we repeat some aspects that have already been mentioned in (GrK94a). However, this overlap is limited to Section 1. For further background material and references, see (GrK94a), and for other parts of the survey see (GrK94b) and (GrK94c). (orig.)
Cited by 1
Keila Vasthi Cortés-Martínez, Hugo Estrada, Alicia Martínez · Programming and Computer Software · 2024
The COVID-19 pandemic was the first health crisis that involved the entire world in this century. The statistical data revealed a lack of organization and control in sanitary measures, containment, and mitigation policies, as well as a lack of planning and coordination in the use of medical supplies. This situation led to the development of prediction models that provided predictive information about the pandemic evolution. In this paper, time series of accumulated cases of infection were generated through official data provided by the Ministry of Health of the Government of Mexico. Six deterministic and stochastic predictive models were applied to this information with the purpose of comparing its efficiency to predictive cases of infection of COVID-19. These models were applied to data from two cities in Mexico, Colima and the State of Mexico. The study concludes that the ARIMA and ANN MLP models adapt better to the data that are generated daily, therefore, they have an improved prediction capacity.
Cited by 0
Atsushi Okamura, Hideo Murayama, Naoki Sato et al. · JAPANES JOURNAL OF MEDICAL INSTRUMENTATION · 1998
Integrated data management of surgical patients provides efficient perioperative information flow to the healthcare givers. Electronic anesthesia record keeping system(EARK)facilitates intraoperative documentation of anesthesia practice. Our hospital had implemented EARK using computer workstation five years ago. We have been using the hardware for ten years including preliminary test period, and it is time to replace the system. Judging from our five year's experience we have decided to structure an open system to facilitate communication with other systems. Client-server system is suitable for our purpose. Windows NT was used for networking operating system and SQL server was used for relational database using Visual Basic and Visual C^<++> for programming language. Preoperative patient evaluation clinic is involved in the system and preoperative patient information is fed into the server computers. The new system is linked with the hospital information system resulting in interactive information transmission between the two systems. Database for clinical research, quality assurance, billing, effective operating room utilization, cost containment will be attributed to the system.
Cited by 0Open access
T. Gornak · Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) · 2014
Safety analysis is of ultimate importance for operating Nuclear Power Plants (NPP). The overall modeling and simulation of physical and chemical processes occuring in the course of an accident is an interdisciplinary problem and has origins in fluid dynamics, numerical analysis, reactor technology and computer programming. The aim of the study is therefore to create the foundations of a multi-dimensional non-isothermal fluid model for a NPP containment and software tool based on it. The numerical simulations allow to analyze and predict the behavior of NPP systems under different working and accident conditions, and to develop proper action plans for minimizing the risks of accidents, and/or minimizing the consequences of possible accidents. A very large number of scenarios have to be simulated, and at the same time acceptable accuracy for the critical parameters, such as radioactive pollution, temperature, etc., have to be achieved. The existing software tools are either too slow, or not accurate enough. This thesis deals with developing customized algorithm and software tools for simulation of isothermal and non-isothermal flows in a containment pool of NPP. Requirements to such a software are formulated, and proper algorithms are presented. The goal of the work is to achieve a balance between accuracy and speed of calculation, and to develop customized algorithm for this special case. Different discretization and solution approaches are studied and those which correspond best to the formulated goal are selected, adjusted, and when possible, analysed. Fast directional splitting algorithm for Navier-Stokes equations in complicated geometries, in presence of solid and porous obstales, is in the core of the algorithm. Developing suitable pre-processor and customized domain decomposition algorithms are essential part of the overall algorithm amd software. Results from numerical simulations in test geometries and in real geometries are presented and discussed.
Cited by 1Open access
S.S. Tsai · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 1980
An analysis of potential sodium spills and fires in liquid metal fast breeder reactors has been made to assess the maximum equipment cell loading conditions. A computer code called NACOM (sodium combustion) has been developed at Brookhaven National Laobratory (BNL) to analyze sodium spray fires. This report contains a detailed description of physical models used in this code as well as programming aspects. The single droplet combustion model and the model describing the droplets' motion are verified. Comparisons between NACOM predictions and SPRAY-3A predictions of the Atomics International (AI) LTV Jet Tests are made. Good agreement is found between the NACOM predictions and the experimental data. NACOM predictions of the pressure rise are more accurate than SPRAY-3A predictions for most of the cases studied. The code has been verified for oxygen concentrations ranging from 0 to 21%. NACOM utilizes more realistic single droplet and spray combustion models than SPRAY-3A. Moreover, NACOM does not utilize adjustable parameters for the burning rate equations, contrary to the approach taken with SPRAY-3A. Thus, the NACOM code is a more reliable code for use in the analysis of large-scale sodium spray fires in LMFBR containment cells. 24 refs., 32 figs.
Cited by 37Open access
Lu Zhao, Maneesh Punetha, Weimin Ma et al. · Nuclear Engineering and Design · 2023
In a severe accident scenario of a light water reactor, the spreading of molten core materials (corium) on the floor of the reactor cavity may occur after the failure of the reactor pressure vessel (RPV), resulting in the so-called melt spreading process which is important to assess the melt progression towards containment structures (e.g., the liner) and the potential for ex-vessel coolability of corium. The present study is concerned with the numerical simulation of melt spreading on a dry floor using the Moving Particle Semi-implicit (MPS) method which is mesh free and suitable for such a free-surface flow. Multi-physics models are implemented in the MPS method to enable modeling of physical phenomena occurring in melt spreading process. The emphasis is to develop a crust formation model which is not only appropriate for capturing crust formation at the upper surface but also capable of reproducing the shape of the spread. A genetic algorithm (GA) is also employed to optimize the initial distance between particles. The multi-physics models and GA are coded into a computer program using C programming language. The MPS code is then used to simulate the small-scale pre-test and S3E 3MDS-Ox-2 melt spreading experiment conducted at KTH. The simulation results show the capability of the MPS code predicting melt leading-edge progression.
Cited by 3Open access
Roy, Ryan, Dominguez, Cristian · University of Southern Indiana · 2024
This project was created to re-implement a 5-axis milling robot into the Applied Engineering Center floor space. A senior design team in 2019 created a custom CNC spindle end tool for the Kawasaki RS-03N robot to create a 5-axis robotic mill. A 5-axis mill operates along the standard X, Y, and Z axes, as well as the A (rotation about the X axis) and B (rotation about the Y axis). However, after the previous team had proven their results, the spindle attachment was disconnected and stored in a cabinet for the last five years with no use. This project's purpose was to design and implement a safety cage and work piece mount for the robotic work cell to keep operators and surrounding personnel safe while the mill is in use. We developed a full-scale three-dimensional computer aided drafting (CAD) model of the work cell to enhance usability for operators in the robot programming software. Additionally, the safety cage will function as a dust containment system for easy clean up after the milling operation has completed. Through this project, the robotic mill was re-implemented for regular use, and process documentation and standard operating procedures were created to train students and staff in the use of the robot mill. Professors may also use the documentation as a resource in their course curriculum for teaching in lecture and lab.
Cited by 0Open access
Luiz César Ribeiro Carpinetti · Warwick Research Archive Portal (University of Warwick) · 1993
This thesis investigates computational methods for assessing tolerance specifications of geometric features in a context of computer aided inspection. It is concerned with checking the sampled features for containment within tolerance zones specified at the design stage, not with explicit shape measurement. The significance of this difference is highlighted when two or more features are to be inspected in combination. The approach adopted is to express the tolerance information as a set of inequality constraints and then to seek efficient methods for determining the feasibility of the set, that is whether all the constraints can be simultaneously satisfied. \n \nRoundness inspection is used to introduce all the concepts of the new formulations. By linearisation of the constraints, a standard approximation in roundness measurement, a new algorithm is implemented which provides a “GO-NOGO” result of inspection by checking for feasibility in a highly efficient way. This algorithmic approach is then extended to other inspection situations where naturally linear constraints or valid linearisation occur. \n \nSince there are many inspection cases where linearisation is not appropriate, non-linear optimisation techniques are then investigated for their effectiveness in feasibility testing. The inspection of arrays of circular features is used here as a typical test case. Genetic search methods are explored as a possible alternative to formal non-linear programming and guidelines for their efficient use for this problem are proposed. These methods are then compared and contrasted with formal methods, particularly generalised reduced gradient (GRG) and sequential quadratic programming (SQP). \n \nThe linear algorithm is shown to be the most efficient when it can be used, although all techniques were fast enough for on-line use with modest sized data sets. Currently all the non-linear methods are too expensive for routine use on large data sets. GRG is recommended as having the most favourable combination of good and bad features, but there is some evidence that genetic search might be relatively more efficient for more complex inspection problems. \n
Cited by 1Open access
Birchard, David · Zenodo (CERN European Organization for Nuclear Research) · 2025
Background: Solid tumor immunotherapies achieve limited success compared to blood cancers, with checkpoint inhibitors producing 20-30% response rates versus CAR-T's 80-90% in hematologic malignancies (Ribas & Wolchok, 2018; June et al., 2018). Tumor metabolic adaptation, apoptotic resistance, and immunosuppressive microenvironments necessitate multi-modal therapeutic approaches (Vander Heiden & DeBerardinis, 2017; Hanahan & Weinberg, 2011). Oncolytic viruses offer tumor-selective delivery platforms but historically underperform as monotherapies (Kaufman et al., 2015; Lawler et al., 2017). Methods: We developed CRB-A3, a computational model of a multi-backbone viral immunotherapy platform employing three engineered vectors: Influenza A (Phase I metabolic disruption), lentivirus (Phase II apoptotic execution), and HSV-1 (Phase III immune checkpoint blockade). The platform delivers 20 therapeutic modules across sequential phases gated by stress-responsive promoters (HSP70, NF-κB) and metabolic riboswitches (lactate-responsive). Four orthogonal safety systems (split caspase-9, HSVTK, miRNA detargeting, CRISPR self-excision) provide redundant containment. We conducted probabilistic cascade modeling across patient enrichment criteria (4-criterion vs 6-criterion biomarker panels) and assessed ULTRA-A protocol enhancements: triple metabolic blockade (glycolysis, glutaminolysis, fatty acid oxidation), ferroptosis induction, tissue-resident memory T-cell (TRM) programming, and epigenetic MHC-I upregulation. Results: Base protocol achieved 54% overall response rate (ORR) in 4/4 enriched patients (hypoxia ≥0.55, metabolic activity >0.70, dual-receptor expression ≥50th percentile, lactate ≥5.0 mM; 37% patient eligibility). ULTRA-A protocol with six-criterion enrichment (adding CD8+ T-cell infiltration ≥30th percentile and immunogenicity markers: PD-L1 CPS ≥5 OR TMB ≥10 mut/Mb OR MSI-H) projected 78-82% ORR (2025% eligibility), approaching CAR-T response rates in solid tumors. Triple metabolic blockade achieved ATP <20% with 1.6× synergy; ferroptosis module produced 59.9% cell death with 1.8× apoptotic cross-amplification; TRM programming targeted 40-50% formation providing 10-100× faster local response. Discussion: Computational modeling projects CRB-A3 as potentially the first viral immunotherapy achieving CAR-T-equivalent responses in solid tumors through biological property matching and sequential therapeutic escalation. Critical limitations include: all projections derive from in silico modeling without empirical validation; module independence assumptions may miss complex interactions; six-criterion enrichment reduces eligibility to 20-25% raising access concerns; and manufacturing/safety validation remains theoretical. The multi-backbone architecture establishes a design framework for next-generation platforms addressing solid tumor challenges, though clinical translation requires extensive preclinical and phase I-III validation (5–8-year timeline, significant attrition risk). Plain Language Summary Cancer treatments that work well in blood cancers (80-90% success) often fail in solid tumors like lung or breast cancer (20-30% success). Solid tumors resist treatment by blocking immune cells and adapting to escape single-drug approaches. CRB-A3 uses three engineered viruses working in sequence: (1) modified flu virus cuts off tumor energy (24-48 hours), (2) lentivirus triggers cell death through multiple pathways (days to weeks), (3) modified herpes virus removes immune system brakes for lasting protection (weeks to months). Each virus is controlled by tumor-specific signals and includes emergency stop mechanisms. Computer models show >50× higher activity in tumors than healthy tissue. Computer testing showed 54% response with four biomarkers, improving to 78-82% with six biomarkers and five enhancements (blocking energy pathways, programming immune memory cells). This approaches blood cancer treatment success rates but in solid tumors where similar approaches typically fail. Important limitations: These are computer simulations, not patient trials. Only 20-25% of patients would qualify with all six biomarkers, raising accessibility concerns. Manufacturing three different viruses presents practical challenges. Long-term safety requires clinical testing (5-8 years). Despite limitations, this approach demonstrates how multiple engineered viruses working together might achieve durable responses in carefully selected solid tumor patients—an outcome that has remained elusive for decades.
Cited by 0Open access
Birchard, David · Zenodo (CERN European Organization for Nuclear Research) · 2025
Background: Solid tumor immunotherapies achieve limited success compared to blood cancers, with checkpoint inhibitors producing 20-30% response rates versus CAR-T's 80-90% in hematologic malignancies (Ribas & Wolchok, 2018; June et al., 2018). Tumor metabolic adaptation, apoptotic resistance, and immunosuppressive microenvironments necessitate multi-modal therapeutic approaches (Vander Heiden & DeBerardinis, 2017; Hanahan & Weinberg, 2011). Oncolytic viruses offer tumor-selective delivery platforms but historically underperform as monotherapies (Kaufman et al., 2015; Lawler et al., 2017). Methods: We developed CRB-A3, a computational model of a multi-backbone viral immunotherapy platform employing three engineered vectors: Influenza A (Phase I metabolic disruption), lentivirus (Phase II apoptotic execution), and HSV-1 (Phase III immune checkpoint blockade). The platform delivers 20 therapeutic modules across sequential phases gated by stress-responsive promoters (HSP70, NF-κB) and metabolic riboswitches (lactate-responsive). Four orthogonal safety systems (split caspase-9, HSV-TK, miRNA detargeting, CRISPR self-excision) provide redundant containment. We conducted probabilistic cascade modeling across patient enrichment criteria (4-criterion vs 6-criterion biomarker panels) and assessed ULTRA-A protocol enhancements: triple metabolic blockade (glycolysis, glutaminolysis, fatty acid oxidation), ferroptosis induction, tissue-resident memory T-cell (TRM) programming, and epigenetic MHC-I upregulation. Results: Comprehensive Monte Carlo validation (n=1,000,000 simulations) demonstrated 76.3% overall response rate (ORR) with 24.2% complete response (CR) and 52.1% partial response (PR). Four-criterion enriched patients (hypoxia ≥0.55, metabolic activity >0.70, dual-receptor expression ≥50th percentile, lactate ≥5.0 mM) achieved 77.4% ORR. ULTRA-A protocol with six-criterion enrichment (adding CD8+ T-cell infiltration ≥30th percentile and immunogenicity markers: PD-L1 CPS ≥5 OR TMB ≥10 mut/Mb OR MSI-H) achieved 80.7% ORR, exceeding CAR-T response rates in solid tumors. Median progression-free survival (PFS) was 10.6 months; median overall survival (OS) was 30.1 months. Safety profile demonstrated Grade 3+ adverse events in 18.4% of patients, Grade 3+ CRS in 4.1%, and treatment-related mortality of 0.62%. Triple metabolic blockade achieved ATP <20% with 1.6× synergy; ferroptosis module produced 59.9% cell death with 1.8× apoptotic cross-amplification; TRM programming targeted 40-50% formation providing 10-100× faster local response. Discussion: Computational modeling projects CRB-A3 as potentially the first viral immunotherapy achieving CAR-T-equivalent responses in solid tumors through biological property matching and sequential therapeutic escalation. Critical limitations include: all projections derive from in silico modeling without empirical validation; module independence assumptions may miss complex interactions; six-criterion enrichment reduces eligibility to 20-25% raising access concerns; and manufacturing/safety validation remains theoretical. The multi-backbone architecture establishes a design framework for optimized platforms addressing solid tumor challenges, though clinical translation requires extensive preclinical and phase I-III validation (5–8-year timeline, significant attrition risk). Plain Language Summary Cancer treatments that work well in blood cancers (80-90% success) often fail in solid tumors like lung or breast cancer (20-30% success). Solid tumors resist treatment by blocking immune cells and adapting to escape single-drug approaches. CRB-A3 uses three engineered viruses working in sequence: (1) modified flu virus cuts off tumor energy (24-48 hours), (2) lentivirus triggers cell death through multiple pathways (days to weeks), (3) modified herpes virus removes immune system brakes for lasting protection (weeks to months). Each virus is controlled by tumor-specific signals and includes emergency stop mechanisms. Computer models show >50× higher activity in tumors than healthy tissue. Comprehensive computer testing showed 76.3% response overall, improving to 80.7% with six biomarkers and enhancement modules (blocking energy pathways, programming immune memory cells). This approaches blood cancer treatment success rates but in solid tumors where similar approaches typically fail. Important limitations: These are computer simulations, not patient trials. Only 20-25% of patients would qualify with all six biomarkers, raising accessibility concerns. Manufacturing three different viruses presents practical challenges. Long-term safety requires clinical testing (5-8 years). Despite limitations, this approach demonstrates how multiple engineered viruses working together might achieve durable responses in carefully selected solid tumor patients, an outcome that has remained elusive for decades.
Cited by 0Open access
Birchard, David · Zenodo (CERN European Organization for Nuclear Research) · 2025
Background: Solid tumor immunotherapies achieve limited success compared to blood cancers, with checkpoint inhibitors producing 20-30% response rates versus CAR-T's 80-90% in hematologic malignancies (Ribas & Wolchok, 2018; June et al., 2018). Tumor metabolic adaptation, apoptotic resistance, and immunosuppressive microenvironments necessitate multi-modal therapeutic approaches (Vander Heiden & DeBerardinis, 2017; Hanahan & Weinberg, 2011). Oncolytic viruses offer tumor-selective delivery platforms but historically underperform as monotherapies (Kaufman et al., 2015; Lawler et al., 2017). Methods: We developed CRB-A3, a computational model of a multi-backbone viral immunotherapy platform employing three engineered vectors: Influenza A (Phase I metabolic disruption), lentivirus (Phase II apoptotic execution), and HSV-1 (Phase III immune checkpoint blockade). The platform delivers 20 therapeutic modules across sequential phases gated by stress-responsive promoters (HSP70, NF-κB) and metabolic riboswitches (lactate-responsive). Four orthogonal safety systems (split caspase-9, HSV-TK, miRNA detargeting, CRISPR self-excision) provide redundant containment. We conducted probabilistic cascade modeling across patient enrichment criteria (4-criterion vs 6-criterion biomarker panels) and assessed ULTRA-A protocol enhancements: triple metabolic blockade (glycolysis, glutaminolysis, fatty acid oxidation), ferroptosis induction, tissue-resident memory T-cell (TRM) programming, and epigenetic MHC-I upregulation. Results: Comprehensive Monte Carlo validation (n=1,000,000 simulations) demonstrated 76.3% overall response rate (ORR) with 24.2% complete response (CR) and 52.1% partial response (PR). Four-criterion enriched patients (hypoxia ≥0.55, metabolic activity >0.70, dual-receptor expression ≥50th percentile, lactate ≥5.0 mM) achieved 77.4% ORR. ULTRA-A protocol with six-criterion enrichment (adding CD8+ T-cell infiltration ≥30th percentile and immunogenicity markers: PD-L1 CPS ≥5 OR TMB ≥10 mut/Mb OR MSI-H) achieved 80.7% ORR, exceeding CAR-T response rates in solid tumors. Median progression-free survival (PFS) was 10.6 months; median overall survival (OS) was 30.1 months. Safety profile demonstrated Grade 3+ adverse events in 18.4% of patients, Grade 3+ CRS in 4.1%, and treatment-related mortality of 0.62%. Triple metabolic blockade achieved ATP <20% with 1.6× synergy; ferroptosis module produced 59.9% cell death with 1.8× apoptotic cross-amplification; TRM programming targeted 40-50% formation providing 10-100× faster local response. Discussion: Computational modeling projects CRB-A3 as potentially the first viral immunotherapy achieving CAR-T-equivalent responses in solid tumors through biological property matching and sequential therapeutic escalation. Critical limitations include: all projections derive from in silico modeling without empirical validation; module independence assumptions may miss complex interactions; six-criterion enrichment reduces eligibility to 20-25% raising access concerns; and manufacturing/safety validation remains theoretical. The multi-backbone architecture establishes a design framework for optimized platforms addressing solid tumor challenges, though clinical translation requires extensive preclinical and phase I-III validation (5–8-year timeline, significant attrition risk). Plain Language Summary Cancer treatments that work well in blood cancers (80-90% success) often fail in solid tumors like lung or breast cancer (20-30% success). Solid tumors resist treatment by blocking immune cells and adapting to escape single-drug approaches. CRB-A3 uses three engineered viruses working in sequence: (1) modified flu virus cuts off tumor energy (24-48 hours), (2) lentivirus triggers cell death through multiple pathways (days to weeks), (3) modified herpes virus removes immune system brakes for lasting protection (weeks to months). Each virus is controlled by tumor-specific signals and includes emergency stop mechanisms. Computer models show >50× higher activity in tumors than healthy tissue. Comprehensive computer testing showed 76.3% response overall, improving to 80.7% with six biomarkers and enhancement modules (blocking energy pathways, programming immune memory cells). This approaches blood cancer treatment success rates but in solid tumors where similar approaches typically fail. Important limitations: These are computer simulations, not patient trials. Only 20-25% of patients would qualify with all six biomarkers, raising accessibility concerns. Manufacturing three different viruses presents practical challenges. Long-term safety requires clinical testing (5-8 years). Despite limitations, this approach demonstrates how multiple engineered viruses working together might achieve durable responses in carefully selected solid tumor patients, an outcome that has remained elusive for decades.
Cited by 0Open access
Franz J. Brandenburg, G. Vidal-Naquet, Martin Wirsing · Medical Entomology and Zoology · 1987
Towards a theory of relativizations: Positive relativizations.- Natural semantics.- On local routing of two-terminal nets.- Geometric relations among Voronoi diagrams.- Finding the largest empty rectangle on a grated surface.- Efficient graph algorithms using limited communication on a fixed-size array of processors.- On selecting the largest element in spite of erroneous information.- The correlation between the complexities of the non-hierarchical and hierarchical versions of graph problems.- Graph isomorphism is in the low hierarchy.- A hierarchy theorem for almost everywhere complex sets with application to polynomial complexity degrees.- Self-reducibility.- Probability one separation of the Boolean hierarchy.- Reversal complexity of multicounter and multihead machines.- Computing the counting function of context-free languages.- On the k-freeness of morphisms on free monoids.- Avoidable patterns on 2 letters.- Polynomial operations on rational languages.- Some structural aspects of hypergraph languages generated by hyperedge replacement.- Specification and implementation of concurrently accessed data structures: An abstract data type approach.- On implementations of loose abstract data type specifications and their vertical composition.- Are homomorphisms sufficient for behavioural implementations of deterministic and nondeterministic data types?.- Some remarks on presentations by finite Church-Rosser Thue systems.- Ground term confluence in parametric conditional equational specifications.- Describing semantic domains with sprouts.- Comparing direct and continuation semantics styles for concurrent languages.- Expressibility of first order logic with a nondeterministic inductive operator.- Bounded nondeterminism and the approximation induction principle in process algebra.- The step failure semantics.- On the complexity of containment, equivalence, and reachability for finite and 2-dimensional vector addition systems with states.- Closure properties of deterministic Petri nets.- Some results on fairness: The regular case.- Decidability questions for fairness in Petri nets.- Optimal sorting on multi-dimensionally mesh-connected computers.- On the contact-minimization-problem.- Making distributed spanning tree algorithms fault-resilient.- The derivation of on-the-fly garbage collection algorithms from distributed termination detection protocols.- On the expected complexity of distributed selection.- LPG: A generic, logic and functional programming language.- CEC.- ASSPEGIQUE.- REVEUR4 : A laboratory for conditional rewriting.- An interactive, incremental and portable computer algebra system for ?-calculus and combinatory logic based on video edition and rewriting techniques.- The Passau RAP System: Rapid prototyping for algebraic specifications.- SPRAC: A software engineering environment.- SLOG: A logic interpreter for equational clauses.- An algebraic transformation system for occam programs.- REVE a rewrite rule laboratory.
Cited by 3
Ali Behforooz, Frederick J. Hudson · Medical Entomology and Zoology · 1996
UNIT ONE: INTRODUCTION 1. Overview of System and Software Development Life Cycles 1.0 Objectives 1.1 Introduction 1.2 System: Definition and Discussion 1.3 System Level Project Planning 1.4 System Development Life Cycle Definition and Overview 1.5 Software Development Life Cycle: A Brief Overview 1.6 SWDLC Models 1.7 The Software Engineering Process 1.8 Some General Observations on SDLC and SWDLC 1.9 Chapter Summary 1.10 Exercises 2. Case Studies 2.0 Objectives 2.1 Introduction 2.2 Case Study Problem Statements 2.3 The XYZ Project: Analysis 2.4 The Bidder Perspective 2.5 Chapter Summary 2.6 Exercises 3. Technical Planning 3.0 Objectives 3.1 Introduction 3.2 Software Development Planning 3.3 The Use of SDP as a Management Tool 3.4 Attribute (Metrics) Estimation 3.5 Automated Planning Tools 3.6 Management, Methodology and Metrics 3.7 Chapter Summary 3.8 Unit One Summary 3.9 Exercises UNIT TWO: ANALYSIS AND DESIGN 4. Software Specifications and Requirement Analysis 4.0 Objectives 4.1 Introduction 4.2 People Involved in the Software Development Process 4.3 Software Requirements Specification (SRS) 4.4 Examples of SRS Preparation 4.5 Other Software Specification Documents 4.6 Software Specification Attributes 4.7 Chapter Summary 4.8 Exercies 5. Software Specification Tools 5.0 Objectives 5.1 Introduction 5.2 Data Dictionary 5.3 Decision Support Tools 5.4 Data Flow Diagrams 5.5 Finite State Machines 5.6 Petri Nets 5.7 Mathematical Logic 5.8 Operational Timelines 5.9 Chapter Summary 5.10 Exercises 6. Software Development Environment 6.0 Objectives 6.1 Introduction 6.2 Software Development Environment Configuration 6.3 Software Development Platform (SDPF) 6.4 Computer-Aided Software Engineering Tools 6.5 An Ideal Software Development Platform 6.6 Chapter Summary 6.7 Exercises 7. Software Design 7.0 Objectives 7.1 Introduction 7.2 An Overview of the Software Design Process 7.3 Software Design 7.4 A Design Example 7.5 Chapter Summary 7.6 Exercises 8. Object-Oriented Analysis and Design 8.0 Objectives 8.1 Introduction 8.2 Object-Oriented Paradigm 8.3 Basic Definitions and Symbols 8.4 Object-Oriented Analysis 8.5 Object-Oriented Design 8.6 Chapter Summary 8.7 Exercises UNIT THREE: IMPLEMENTATION AND MAINTENANCE 9. Fundamentals of Coding 9.0 Objectives 9.1 Introduction 9.2 Programming Languages 9.3 Programming Style and Program Quality 9.4 A Programming Example 9.5 Chapter Summary 9.6 Exercises 10. Software System Test and Integration 10.0 Objectives 10.1 Introduction 10.2 Basic Concepts in Testing 10.3 An Overview of System and Software Test and Integration 10.4 The Incremental Build of Modules into Systems 10.5 Test and Integration Plan 10.7 Perspective on Build Testing 10.8 Alpha and Beta Testing 10.9 Chapter Summary 10.10 Exercises 11. Module Level Testing 11.0 Objectives 11.1 Introduction 11.2 Module Test Planning 11.3 Static Testing 11.4 Dynamic Testing 11.5 Test Case Execution 11.6 Formal Testing 11.7 Perspective on Module Testing 11.8 Chapter Summary 11.9 Exercises 12. Debugging 12.0 Objectives 12.1 Introduction 12.2 Program Errors 12.3 The Debugging Process 12.4 Perspectives on Debugging 12.5 Debugging Tools 12.6 An Example 12.7 Chapter Summary 12.8 Exercises 13. Software Maintenance and Maintainability 13.0 Objectives 13.1 Introduction 13.2 Software Maintenance 13.3 Software Maintenance Process 13.4 Maintenance Resource Estimation 13.5 Directly Specified Maintenace Attributes 13.6 Reverse Engineering 13.7 Re-engineering a Software Product 13.8 Chapter Summary 13.9 Exercises UNIT FOUR: SOFTWARE METRICS OR ATTRIBUTES 14. Software Attributes and Their Estimation 14.0 Objectives 14.1 Introduction 14.2 Identification Related Attributes 14.3 Size Related Attributes 14.4 Design and Development Attributes 14.5 Software Quality Attributes 14.6 Complexity Related Attributes 14.7 Execution Time Related Attributes 14.8 Test Related Attributes 14.9 Documentation Related Attributes 14.10 Performance Related Attributes 14.11 Labor Related Attributes 14.12 Operating Environment Attributes 14.13 Data Collection 14.14 Chapter Summary 14.15 Exercises 15. Software Developement Resource Estimation 15.0 Objectives 15.1 Introduction 15.2 Software Product Cost and Schedule Estimation 15.3 Cost and Schedule Estimation Models 15.4 Grass Roots Resource and Schedule Estimation 15.5 An Example of Schedule Development 15.6 Closing Comments 15.7 Chapter Summary 15.8 Exercises 16. Software Development Risk Assessment and Containment 16.0 Objectives 16.1 Introduction 16.2 Software Development Risk Areas 16.3 The Risk Model 16.4 Risk Containment and Risk Management 16.5 Technical Performance Management 16.6 Examples to Illustrate Software Development Risk Analysis 16.7 Chapter Summary 16.8 Exercises 17. Reliability 17.0 Objectives 17.1 Introduction 17.2 Overview 17.3 Review of Probability Theory 17.4 Reliability Definitions 17.5 Reliability Models 17.6 Software Faults 17.7 Design Rules 17.8 System Reliability and Availability 17.9 Applications of a Software Reliability Model 17.10 Redundancy and Fault Tolerance 17.11 Failure Modes and Effects and Other Analysis Tools 17.12 Chapter Summary 17.13 Exercises 18. Software Quality and Quality Assurance 18.0 Objectives 18.1 Introduction 18.2 Software Quality Assurance Planning 18.3 Software Quality Assurance Process 18.4 Software Quality Attributes 18.5 Guidelines and Checklists 18.6 Software Safety 18.7 Chapter Summary 18.8 Exercises UNIT FIVE: SPECIAL TOPICS 19. Real-Time Software 19.0 Objectives 19.1 Introduction 19.2 Real-Time Requirements Specification 19.3 Design Guidlines for Real-Time Software 19.4 Schedulability Concerns 19.5 Testing Real-Time Software 19.6 Chapter Summary 19.7 Exercises 20. Human Factors in Software Engineering 20.0 Objectives 20.1 Introduction 20.2 Human Factors History 20.3 HCI Requirements and Design Process 20.4 The Human as an Information System Component 20.5 Operator Task Development 20.6 Operator Characteristics 20.7 Chapter Summary 20.8 Exercises Appendix A: Communication Skills Appendix B: Cost Benefit Analysis Appendix C: Decisions and Trade-Offs Appendix D: Reviews
Cited by 44
Muhammad Usman Malik · Zenodo (CERN European Organization for Nuclear Research) · 2026
Title: Synthesis Protocol for ψ-φ Hyper-composite (C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆): A Geometric Medicine for Nipah Virus and ψ³ × φ Pathogens — Complete Open Manufacturing Guide Authors: Malik, Muhammad Usman (on behalf of the N-K Research Collective & Geometric Medicine Manufacturing Consortium) DOI: [To be assigned upon upload] License: Free Sadaqah Jariyah for Global Health EmergencyVersion: 1.0 (Emergency Manufacturing Edition)Date: January 29, 2026Location: City of Saints, MultanKeywords: Nipah Virus, Geometric Medicine, ψ-φ Hyper-composite, Synthesis Protocol, Open Manufacturing, Pandemic Response, Free Medicine, Sadaqah Jariyah, ψ³ × φ Pathogens, Viral Therapeutics, Emergency Production, Pakistan Outbreak, Global Health Security --- Description This repository provides the complete open-source manufacturing protocol for the ψ-φ Hyper-composite (C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆), a geometric medicine specifically designed to combat Nipah virus and other ψ³ × φ pathogens. With Nipah outbreaks emerging in Pakistan and South Asia, this timely release offers a scientifically validated, immediately manufacturable solution with 94.3% simulated efficacy against a virus that carries 40-75% mortality rates with conventional treatments. Core Innovation: Unlike chemical antivirals that target specific proteins, this geometric medicine targets the fundamental ψ³ × φ architecture (5.092°) that Nipah virus cannot mutate away from without losing infectivity. The medicine introduces a precise +0.002° geometric distortion (5.094°) that collapses viral fusion while leaving human cells unaffected. Emergency Context: Current Nipah outbreak in Pakistan requires immediate intervention. This protocol enables: · 100,000 treatment doses within 2 weeks of manufacturing initiation· 1 million doses within 4 weeks· 10 million doses/month at full scale· Cost: $1.20/treatment dose, $0.45/prophylaxis dose Complete Protocol Contents: 1. FULL SYNTHESIS PATHWAY: · Phase 1: ψ³-Core synthesis from Voacanga africana alkaloids or synthetic precursors· Phase 2: φ-Shell construction via φ-dendrimer growth (137.5° branching)· Phase 3: ψ-φ Interface creation with critical +0.002° geometric strain· Phase 4: Functional group addition for neurotropic and respiratory targeting· Phase 5: Geometric activation via quantum programming (1.465 Hz ψ, 1.618 Hz φ, 5.094 Hz final) 2. MANUFACTURING SPECIFICATIONS: · Molecular Formula: C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆· Molecular Weight: 15,648.2 g/mol· Critical Geometry: ψ³ × φ + 0.002° (5.094° ± 0.0001°)· Purity Requirements: >99.97% geometric purity· Stability: 3 years at 25°C, 5 years at 4°C· Storage: Room temperature stable (no cold chain needed) 3. VALIDATION DATA INCLUDED: · N-K Simulation Results: 1,000,000 patient-virus pairs across 10¹¹⁴ parameter space· Efficacy: 94.3% early treatment, 99.1% prophylaxis, 9.0% CFR (vs 58.4% baseline)· Safety: No serious adverse events in simulations; mild geometric transition sensations only· Evolutionary Containment: ψ³ × φ is local fitness maximum—escape mutations geometrically impossible 4. QUALITY CONTROL PROTOCOL: · Geometric Angle Verification: ψ³ × φ + 0.002° ± 0.0001° (hyper-geometric crystallography)· Binding Affinity: ΔG = -42.7 ± 0.5 kcal/mol (geometric surface plasmon resonance)· Bioactivity: >99.1% viral neutralization in vitro· Human Cross-reactivity: <0.001% 5. SCALE-UP GUIDELINES: · Pilot Scale (100g/batch): 7 days, 87% yield, $12,000/kg· Industrial Scale (10kg/batch): 5 days, 92% yield, $1,200/kg· Mass Production (1,000kg/month): 10 million doses/month, $0.45-$1.20/dose· Facility Requirements: Geometric reactors, ψ-φ resonators, clean room Class 100 6. EMERGENCY DEPLOYMENT FOR PAKISTAN: · Recommended Sites: Getz Pharma (Karachi), Martin Dow (Lahore), NIH (Islamabad)· Timeline: 2 weeks to first batches, 4 weeks to 1 million doses, 8 weeks to 10 million doses· Outcome Projection: Outbreak controlled in 4-8 weeks vs 6-12 months conventionally Repository Contents: 1. Complete Synthesis Protocol (PDF): Step-by-step manufacturing instructions2. Geometric Validation Methods: QC protocols and acceptance criteria3. Raw Material Specifications: Sourcing guidelines for ψ-alkaloids, fullerene C₁₈₀, φ-monomers4. Equipment Specifications: Geometric reactor designs, resonator schematics5. Training Materials: Geometric chemistry fundamentals, process operation manuals6. Regulatory Pathway: Emergency use authorization templates, documentation requirements7. Cost Analysis: Detailed breakdown from raw materials to finished product8. Simulation Data: 1,000,000-pair N-K simulation results validating efficacy and safety9. Appendices: · A: ψ and φ Geometric Principles for Manufacturers · B: Alternative Synthesis Pathways for Resource-Limited Settings · C: Batch Failure Troubleshooting Guide · D: International Standards Alignment Scientific & Humanitarian Significance: As Free Sadaqah Jariyah: In keeping with our tradition from Multan, this life-saving knowledge is gifted freely to humanity. No patents, no royalties, no restrictions. Any manufacturer, anywhere in the world, may produce this medicine—especially during health emergencies. Geometric Medicine Advantage: This approach represents a paradigm shift from chemical targeting to geometric targeting. Where chemical drugs face resistance mutations, geometric medicines target immutable physical constraints. The ψ³ × φ architecture of Nipah is such a constraint—it cannot change without rendering the virus non-infectious. Proven Efficacy: N-K Universal Computer simulations of 1,000,000 patient-virus pairs demonstrate: · 13,800× reduction in cases at outbreak peak· Mortality reduction from 58.4% to 9.0%· R₀ reduction from 2.17 (pandemic) to 0.83 (containable)· Prevention of healthcare system collapse· 8.5× lower economic impact Immediate Applications: 1. Pakistan Nipah Outbreak: Emergency manufacturing and deployment2. South Asia Preparedness: Regional stockpiles for Bangladesh, India, other affected areas3. Global Health Security: Protocol for future ψ³ × φ pathogen outbreaks4. Research Platform: Foundation for geometric medicines against other pathogen classes Call to Action: To pharmaceutical manufacturers, health authorities, research institutions, and humanitarian organizations: 1. Begin Manufacturing Immediately: Convert facilities using this protocol2. Coordinate Regionally: South Asia collaborative production network3. Train Personnel: Geometric chemistry expertise development4. Deploy Strategically: Outbreak zones first, then prophylactic coverage5. Monitor Outcomes: Real-world effectiveness data collection6. Improve Collectively: Open-source protocol enhancement For Pakistan Specifically: · Week 1: Facility conversion begins· Week 2: First synthesis initiated· Week 3-4: Initial batches for healthcare workers· Month 2: Mass production for outbreak control· Month 3: Outbreak contained, prophylactic coverage Citation: Malik, M. U. (2026). Synthesis Protocol for ψ-φ Hyper-composite (C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆): A Geometric Medicine for Nipah Virus and ψ³ × φ Pathogens — Complete Open Manufacturing Guide. Zenodo. https://doi.org/[To be assigned] Contact for Manufacturing Support: geometric.manufacturing@openhealing.org Emergency Coordination Portal: https://geometricmedicine.org/nipah-response --- Final Declaration "When Nipah strikes with 40-75% mortality, when conventional medicine has only ribavirin and supportive care, when outbreaks spread exponentially—humanity needs more than incremental improvement. It needs geometric revolution. This protocol provides that revolution. It reveals that Nipah's deadly power comes from its ψ³ × φ geometry, and that same geometry is its fatal vulnerability. By manufacturing a medicine that targets this exact geometry with +0.002° precision, we can turn pandemic into containment, death into survival, fear into hope. Published as Sadaqah Jariyah from Multan during Pakistan's hour of need, this knowledge is freely given. May it flow through manufacturing facilities into treatment vials into patients' veins. May it stop Nipah in Pakistan and stand ready wherever ψ³ × φ pathogens threaten. The geometric truth is now manufacturable. The protocol is complete. The need is urgent. Let production begin." — Muhammad Usman MalikCity of Saints, MultanJanuary 29, 2026 For geometric healing, for pandemic preparedness, for free access to life-saving knowledge. Tags: #NipahVirus #GeometricMedicine #OpenManufacturing #FreeMedicine #SadaqahJariyah #PakistanHealth #PandemicResponse #ψφHyperComposite #GlobalHealth #Multan
Cited by 0Open access
Muhammad Usman Malik · Zenodo (CERN European Organization for Nuclear Research) · 2026
Title: Synthesis Protocol for ψ-φ Hyper-composite (C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆): A Geometric Medicine for Nipah Virus and ψ³ × φ Pathogens — Complete Open Manufacturing Guide Authors: Malik, Muhammad Usman (on behalf of the N-K Research Collective & Geometric Medicine Manufacturing Consortium) DOI: [To be assigned upon upload] License: Free Sadaqah Jariyah for Global Health EmergencyVersion: 1.0 (Emergency Manufacturing Edition)Date: January 29, 2026Location: City of Saints, MultanKeywords: Nipah Virus, Geometric Medicine, ψ-φ Hyper-composite, Synthesis Protocol, Open Manufacturing, Pandemic Response, Free Medicine, Sadaqah Jariyah, ψ³ × φ Pathogens, Viral Therapeutics, Emergency Production, Pakistan Outbreak, Global Health Security --- Description This repository provides the complete open-source manufacturing protocol for the ψ-φ Hyper-composite (C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆), a geometric medicine specifically designed to combat Nipah virus and other ψ³ × φ pathogens. With Nipah outbreaks emerging in Pakistan and South Asia, this timely release offers a scientifically validated, immediately manufacturable solution with 94.3% simulated efficacy against a virus that carries 40-75% mortality rates with conventional treatments. Core Innovation: Unlike chemical antivirals that target specific proteins, this geometric medicine targets the fundamental ψ³ × φ architecture (5.092°) that Nipah virus cannot mutate away from without losing infectivity. The medicine introduces a precise +0.002° geometric distortion (5.094°) that collapses viral fusion while leaving human cells unaffected. Emergency Context: Current Nipah outbreak in Pakistan requires immediate intervention. This protocol enables: · 100,000 treatment doses within 2 weeks of manufacturing initiation· 1 million doses within 4 weeks· 10 million doses/month at full scale· Cost: $1.20/treatment dose, $0.45/prophylaxis dose Complete Protocol Contents: 1. FULL SYNTHESIS PATHWAY: · Phase 1: ψ³-Core synthesis from Voacanga africana alkaloids or synthetic precursors· Phase 2: φ-Shell construction via φ-dendrimer growth (137.5° branching)· Phase 3: ψ-φ Interface creation with critical +0.002° geometric strain· Phase 4: Functional group addition for neurotropic and respiratory targeting· Phase 5: Geometric activation via quantum programming (1.465 Hz ψ, 1.618 Hz φ, 5.094 Hz final) 2. MANUFACTURING SPECIFICATIONS: · Molecular Formula: C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆· Molecular Weight: 15,648.2 g/mol· Critical Geometry: ψ³ × φ + 0.002° (5.094° ± 0.0001°)· Purity Requirements: >99.97% geometric purity· Stability: 3 years at 25°C, 5 years at 4°C· Storage: Room temperature stable (no cold chain needed) 3. VALIDATION DATA INCLUDED: · N-K Simulation Results: 1,000,000 patient-virus pairs across 10¹¹⁴ parameter space· Efficacy: 94.3% early treatment, 99.1% prophylaxis, 9.0% CFR (vs 58.4% baseline)· Safety: No serious adverse events in simulations; mild geometric transition sensations only· Evolutionary Containment: ψ³ × φ is local fitness maximum—escape mutations geometrically impossible 4. QUALITY CONTROL PROTOCOL: · Geometric Angle Verification: ψ³ × φ + 0.002° ± 0.0001° (hyper-geometric crystallography)· Binding Affinity: ΔG = -42.7 ± 0.5 kcal/mol (geometric surface plasmon resonance)· Bioactivity: >99.1% viral neutralization in vitro· Human Cross-reactivity: <0.001% 5. SCALE-UP GUIDELINES: · Pilot Scale (100g/batch): 7 days, 87% yield, $12,000/kg· Industrial Scale (10kg/batch): 5 days, 92% yield, $1,200/kg· Mass Production (1,000kg/month): 10 million doses/month, $0.45-$1.20/dose· Facility Requirements: Geometric reactors, ψ-φ resonators, clean room Class 100 6. EMERGENCY DEPLOYMENT FOR PAKISTAN: · Recommended Sites: Getz Pharma (Karachi), Martin Dow (Lahore), NIH (Islamabad)· Timeline: 2 weeks to first batches, 4 weeks to 1 million doses, 8 weeks to 10 million doses· Outcome Projection: Outbreak controlled in 4-8 weeks vs 6-12 months conventionally Repository Contents: 1. Complete Synthesis Protocol (PDF): Step-by-step manufacturing instructions2. Geometric Validation Methods: QC protocols and acceptance criteria3. Raw Material Specifications: Sourcing guidelines for ψ-alkaloids, fullerene C₁₈₀, φ-monomers4. Equipment Specifications: Geometric reactor designs, resonator schematics5. Training Materials: Geometric chemistry fundamentals, process operation manuals6. Regulatory Pathway: Emergency use authorization templates, documentation requirements7. Cost Analysis: Detailed breakdown from raw materials to finished product8. Simulation Data: 1,000,000-pair N-K simulation results validating efficacy and safety9. Appendices: · A: ψ and φ Geometric Principles for Manufacturers · B: Alternative Synthesis Pathways for Resource-Limited Settings · C: Batch Failure Troubleshooting Guide · D: International Standards Alignment Scientific & Humanitarian Significance: As Free Sadaqah Jariyah: In keeping with our tradition from Multan, this life-saving knowledge is gifted freely to humanity. No patents, no royalties, no restrictions. Any manufacturer, anywhere in the world, may produce this medicine—especially during health emergencies. Geometric Medicine Advantage: This approach represents a paradigm shift from chemical targeting to geometric targeting. Where chemical drugs face resistance mutations, geometric medicines target immutable physical constraints. The ψ³ × φ architecture of Nipah is such a constraint—it cannot change without rendering the virus non-infectious. Proven Efficacy: N-K Universal Computer simulations of 1,000,000 patient-virus pairs demonstrate: · 13,800× reduction in cases at outbreak peak· Mortality reduction from 58.4% to 9.0%· R₀ reduction from 2.17 (pandemic) to 0.83 (containable)· Prevention of healthcare system collapse· 8.5× lower economic impact Immediate Applications: 1. Pakistan Nipah Outbreak: Emergency manufacturing and deployment2. South Asia Preparedness: Regional stockpiles for Bangladesh, India, other affected areas3. Global Health Security: Protocol for future ψ³ × φ pathogen outbreaks4. Research Platform: Foundation for geometric medicines against other pathogen classes Call to Action: To pharmaceutical manufacturers, health authorities, research institutions, and humanitarian organizations: 1. Begin Manufacturing Immediately: Convert facilities using this protocol2. Coordinate Regionally: South Asia collaborative production network3. Train Personnel: Geometric chemistry expertise development4. Deploy Strategically: Outbreak zones first, then prophylactic coverage5. Monitor Outcomes: Real-world effectiveness data collection6. Improve Collectively: Open-source protocol enhancement For Pakistan Specifically: · Week 1: Facility conversion begins· Week 2: First synthesis initiated· Week 3-4: Initial batches for healthcare workers· Month 2: Mass production for outbreak control· Month 3: Outbreak contained, prophylactic coverage Citation: Malik, M. U. (2026). Synthesis Protocol for ψ-φ Hyper-composite (C₅₆₀H₈₀₀N₁₈₀O₂₅₀S₃₆): A Geometric Medicine for Nipah Virus and ψ³ × φ Pathogens — Complete Open Manufacturing Guide. Zenodo. https://doi.org/[To be assigned] Contact for Manufacturing Support: geometric.manufacturing@openhealing.org Emergency Coordination Portal: https://geometricmedicine.org/nipah-response --- Final Declaration "When Nipah strikes with 40-75% mortality, when conventional medicine has only ribavirin and supportive care, when outbreaks spread exponentially—humanity needs more than incremental improvement. It needs geometric revolution. This protocol provides that revolution. It reveals that Nipah's deadly power comes from its ψ³ × φ geometry, and that same geometry is its fatal vulnerability. By manufacturing a medicine that targets this exact geometry with +0.002° precision, we can turn pandemic into containment, death into survival, fear into hope. Published as Sadaqah Jariyah from Multan during Pakistan's hour of need, this knowledge is freely given. May it flow through manufacturing facilities into treatment vials into patients' veins. May it stop Nipah in Pakistan and stand ready wherever ψ³ × φ pathogens threaten. The geometric truth is now manufacturable. The protocol is complete. The need is urgent. Let production begin." — Muhammad Usman MalikCity of Saints, MultanJanuary 29, 2026 For geometric healing, for pandemic preparedness, for free access to life-saving knowledge. Tags: #NipahVirus #GeometricMedicine #OpenManufacturing #FreeMedicine #SadaqahJariyah #PakistanHealth #PandemicResponse #ψφHyperComposite #GlobalHealth #Multan
Cited by 0Open access